第一单位:
Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.;European Cell-Based Assays Interest Group.
作者:
Peter,Horvath [1]
;
Nathalie,Aulner [2]
;
Marc,Bickle [3]
;
Anthony M,Davies [4]
;
Elaine Del,Nery [5]
;
Daniel,Ebner [6]
;
Maria C,Montoya [7]
;
Päivi,Östling [8]
;
Vilja,Pietiäinen [9]
;
Leo S,Price [10]
;
Spencer L,Shorte [2]
;
Gerardo,Turcatti [11]
;
Carina,von Schantz [9]
;
Neil O,Carragher [12]
作者单位:
Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.;European Cell-Based Assays Interest Group.
[1]
Imagopole-Citech, Institut Pasteur, Paris 75015, France.;European Cell-Based Assays Interest Group.
[2]
Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden 01307, Germany.;European Cell-Based Assays Interest Group.
[3]
Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology, Brisbane 4102 QLD, Australia; and The Irish National Centre for High Content Screening and Analysis, Trinity Translational Medicine Institute, Trinity College Dublin, Phase 3 Trinity Health Sciences 1.20, St James Hospital, Dublin D8, Republic of Ireland.;European Cell-Based Assays Interest Group.
[4]
Institut Curie, PSL Research University, Department of Translational Research, The Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), F-75005, Paris, France.;European Cell-Based Assays Interest Group.
[5]
Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.;European Cell-Based Assays Interest Group.
[6]
Cellomics Unit, Cell Biology &Physiology Program, Cell &Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.;European Cell-Based Assays Interest Group.
[7]
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.;Science for Life Laboratory, Department of Oncology and Pathology, Karolinska Institutet, Stockholm 17165, Sweden.;European Cell-Based Assays Interest Group.
[8]
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.;European Cell-Based Assays Interest Group.
[9]
Faculty of Science, Leiden Academic Centre for Drug Research, Toxicology, Universiteit Leiden, The Netherlands; and at OcellO, J.H Oortweg 21, 2333 CH, Leiden, The Netherlands.;European Cell-Based Assays Interest Group.
[10]
Biomolecular Screening Facility, Swiss Federal Institute of Technology (EPFL), Lausanne CH-1015, Switzerland.;European Cell-Based Assays Interest Group.
[11]
Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK.;European Cell-Based Assays Interest Group.
[12]
DOI
10.1038/nrd.2016.175
PMID
27616293
发布时间
2018-11-13